Patients Could Lose Telehealth Access to Opioid Addiction Treatment

Patients Could Lose Telehealth Access to Opioid Addiction Treatment

Patients being treated virtually for opioid addiction may have to return to in-person care if the federal government doesn't extend regulations allowing these types of telemedicine visits, Politico reported June 20. The public health emergency for the COVID-19 pandemic greatly expanded access to telehealth, waiving the face-to-face requirement for the prescribing of buprenorphine for opioid use disorder. But that order is set to expire as soon as October, and the U.S. Drug Enforcement Agency has missed deadlines to allow patients to receive controlled substances without in-person appointments, according to Politico. “If we now remove the flexibilities with telehealth, we will make the problem even worse,” Nora Volkow, director of the National Institute on Drug Abuse, told the news outlet. 

Continue reading at


Next Article

  • Patients Could Lose Telehealth Access to Opioid Addiction Treatment

    What Hospital Success Looks Like Under Value-Based Care

    Hospitals are increasingly turning to value-based care initiatives to transform care delivery, lower the total cost of care, and improve patient outcomes. Unlike traditional fee-for-service (FFS) …

    Posted Jun 25, 2022

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2022 Netspective Media LLC. All Rights Reserved.

Built on Dec 2, 2022 at 2:33pm